Provectus Biopharmaceuticals, Inc. (PVCT)

PVCT Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 4, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	48	40	45	23	23	25
Market Cap Growth	15.96%	-11.35%	96.93%	-1.55%	-5.21%	28.54%
Enterprise Value	51	43	48	23	46	44
Last Close Price	0.11	0.10	0.11	0.06	0.06	0.06
PS Ratio	66.08	72.21	45.93	-	-	-
PB Ratio	-7.58	-5.30	-7.29	-5.51	-0.78	-1.03
EV/Sales Ratio	69.81	77.25	48.64	-	-	-
Debt / Equity Ratio	-0.52	-0.40	-0.35	-0.42	-0.79	-0.86
Asset Turnover	0.58	0.32	0.36	-	-	-
Quick Ratio	0.03	0.01	0.00	0.09	0.00	0.20
Current Ratio	0.12	0.15	0.23	0.45	0.01	0.33
Return on Assets (ROA)	-108.92%	-89.58%	-64.62%	-141.40%	-298.62%	-222.42%
Earnings Yield	-6.33%	-7.70%	-7.82%	-24.01%	-28.50%	-28.00%
FCF Yield	-7.14%	-6.39%	-6.69%	-4.39%	-17.44%	-25.04%
Buyback Yield / Dilution	-0.03%	-0.01%	-2.76%	-3.81%	-1.72%	-1.11%
Total Shareholder Return	-0.03%	-0.01%	-2.76%	-3.81%	-1.72%	-1.11%

Source: S&P Capital IQ. Standard template. Financial Sources.